ArticleFrontiers in big data2023
NuSegDA: Domain adaptation for nuclei segmentation.
Article in Frontiers in big data, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Improving generalization capability of deep learning-based nuclei instance segmentation by non-deterministic train time and deterministic test time stain normalization.Computational and structural biotechnology journal · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The accurate segmentation of nuclei is crucial for cancer diagnosis and further clinical treatments. To successfully train a nuclei segmentation network in a fully-supervised manner for a particular type of organ or cancer, we need the dataset with ground-truth annotations. However, such well-annotated nuclei segmentation datasets are highly rare, and manually labeling an unannotated dataset is an expensive, time-consuming, and tedious process. Consequently, we require to discover a way for training the nuclei segmentation network with unlabeled dataset. In this paper, we propose a model named NuSegUDA for nuclei segmentation on the unlabeled dataset (target domain). It is achieved by applying Unsupervised Domain Adaptation (UDA) technique with the help of another labeled dataset (source domain) that may come from different type of organ, cancer, or source. We apply UDA technique at both of feature space and output space. We additionally utilize a reconstruction network and incorporate adversarial learning into it so that the source-domain images can be accurately translated to the target-domain for further training of the segmentation network. We validate our proposed NuSegUDA on two public nuclei segmentation datasets, and obtain significant improvement as compared with the baseline methods. Extensive experiments also verify the contribution of newly proposed image reconstruction adversarial loss, and target-translated source supervised loss to the performance boost of NuSegUDA. Finally, considering the scenario when we have a small number of annotations available from the target domain, we extend our work and propose NuSegSSDA, a Semi-Supervised Domain Adaptation (SSDA) based approach.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.